why does oral glutathione have poor bioavailability Boost Your Health with IV Therapy at Home glutathione oral absorption poor A

**BPC-157, a synthetic gastric pentadecapeptide studied primarily in animal models for tissue repair, gut healing, and anti-inflammatory effects, remains unapproved by the FDA as a finished drug with only limited small-scale human data available.** It was placed in Category 2 in 2023 due to concerns over immunogenicity, peptide impurities, and insufficient safety information for compounding under Section 503A

If phenobarbital is utilized in a patient with hepatic dysfunction, it should be dose-reduced

Finkelstein J, Martin J: Methionine metabolism in mammals: distribution of homocysteine between competing pathways

Aside from its detoxification role, it is important for a variety of essential cellular reactions

Mildly affected patients experience a compensated haemolytic anaemia because mutations affect stability of the enzyme